In summary, our research provides a novel view that the lncRNA PP7080/miR-601/SIRT1 axis is involved in the growth of HCC, which indicated that lncRNA PP7080/miR-601/SIRT1 axis may be a potential diagnosis and therapeutic biomarker of HCC. The gene discussed is SIRT1; the disease is hepatocellular carcinoma.